Injection device
Latest NOVARTIS AG Patents:
- Compounds and compositions for the treatment of coronaviral related diseases
- TRISPECIFIC BINDING MOLECULES AGAINST TUMOR-ASSOCIATED ANTIGENS AND USES THEREOF
- Treatment for lupus nephritis using anti-BAFFR antibodies
- Anti-IgE antibody therapy for multiple food allergies
- Glue degraders and methods of use thereof
Description
Portions of the design shown in broken lines are visible through transparent components of the injection device and form no part of the design as claimed.
Claims
The ornamental design for an injection device, as shown and described.
Referenced Cited
U.S. Patent Documents
| 7651512 | January 26, 2010 | Chelak |
| D827127 | August 28, 2018 | Donnelly |
| D830539 | October 9, 2018 | Boyaval |
| D841155 | February 19, 2019 | McMenamin |
| D841156 | February 19, 2019 | McMenamin |
| D862690 | October 8, 2019 | Jansen |
| D869647 | December 10, 2019 | Dorsey |
| D888942 | June 30, 2020 | Cannamela |
| D897184 | September 29, 2020 | Perkins, Jr. |
| D897185 | September 29, 2020 | Perkins, Jr. |
| D903856 | December 1, 2020 | Nicholas |
| D910836 | February 16, 2021 | Sandberg |
| D910837 | February 16, 2021 | Ono |
Patent History
Patent number: D928942
Type: Grant
Filed: Dec 12, 2019
Date of Patent: Aug 24, 2021
Assignee: NOVARTIS AG (Basel)
Inventors: Neil Cammish (Manchester), John Palmer-Felgate (Horsham), Mark Horlock (Warrington), Congyi Huang (Klagenfurt), Adrian Von Muralt (Basel)
Primary Examiner: David G Muller
Application Number: 29/716,824
Type: Grant
Filed: Dec 12, 2019
Date of Patent: Aug 24, 2021
Assignee: NOVARTIS AG (Basel)
Inventors: Neil Cammish (Manchester), John Palmer-Felgate (Horsham), Mark Horlock (Warrington), Congyi Huang (Klagenfurt), Adrian Von Muralt (Basel)
Primary Examiner: David G Muller
Application Number: 29/716,824
Classifications
Current U.S. Class:
Hand Actuated Flow Control (e.g., Lever, Button, Etc.) (D24/113)